CG Oncology, Inc. Common stock logo CGON - CG Oncology, Inc. Common stock

Price: -- -- | CONSENSUS: Buy DETAILS
STRONG
BUY
0
BUY 10
HOLD 0
SELL 0
STRONG
SELL
0
| PRICE TARGET: $82.57 DETAILS
HIGH: $93.00
LOW: $70.00
MEDIAN: $82.00
CONSENSUS: $82.57
UPSIDE: 28.51%
Metric 2026 Q1 2025 Q4 2025 Q3 2025 Q2 2025 Q1 2024 Q4 2024 Q3 2024 Q2 2024 Q1 2023 Q4 2023 Q3 2023 Q2 2023 Q1 2022 Q4
Revenue
Revenue 1.1 2.3 1.7 0 0.1 0.5 0.0 0.1 0.5 0.0 0.0 0 0.2 0
Cost of Revenue 3.0 2.9 1.6 0 0 0 0 0 0.0 0.0 11.7 0.0 7.8 0.0
Gross Profit (1.9) (0.6) 0.1 0 0.1 0.5 0.0 0.1 0.5 (0.0) (11.7) (0.0) (7.6) (0.0)
Operating Expenses
R&D Expenses 43.7 30.0 27.9 31.3 27.5 26.8 19.6 18.5 17.2 15.9 11.7 9.8 7.8 7.7
SG&A Expenses 20.8 18.0 23.3 17.4 14.8 11.7 8.7 7.5 5.8 3.0 2.3 2.5 2.1 1.7
Other Expenses 0 0.2 0 0 0 0 0 0 0 0 (11.7) (0.1) (7.8) 0.0
Operating Expenses 64.5 48.1 51.2 48.7 42.3 38.5 28.3 26.0 23.0 18.9 2.3 12.3 2.1 9.3
Operating Income
Operating Income (66.4) (48.7) (51.1) (48.7) (42.2) (38.0) (28.3) (25.9) (22.5) (18.9) (14.0) (12.3) (9.7) (9.3)
Interest Expense 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Interest Income 6.3 22.5 7.4 7.3 7.7 6.2 7.9 6.9 5.5 2.8 2.3 0.8 1.0 0.9
Profitability
EBITDA (65.5) (40.5) (43.4) (48.6) (42.2) (38.0) (28.3) (25.8) (22.5) (18.9) (14.0) (12.3) (9.7) (9.5)
EBIT (66.4) (41.3) (43.8) (48.7) (42.2) (38.0) (28.3) (25.9) (22.5) (18.9) (14.0) (12.3) (9.7) (9.5)
Income Before Tax (60.2) (41.3) (43.8) (41.4) (34.5) (31.8) (20.4) (18.9) (16.9) (16.1) (11.8) (11.6) (8.7) (8.4)
Income Tax Expense 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Net Income (60.2) (41.3) (43.8) (41.4) (34.5) (31.8) (20.4) (18.9) (16.9) (16.1) (11.8) (11.6) (8.7) (8.4)
Per Share Data
EPS (Basic) -0.71 -0.52 -0.57 -0.54 -0.45 -0.49 -0.30 -0.28 -0.25 -0.33 -0.28 -0.17 -0.13 -0.13
EPS (Diluted) -0.71 -0.52 -0.57 -0.54 -0.45 -0.49 -0.30 -0.28 -0.22 -0.33 -0.28 -0.17 -0.13 -0.13
Shares Outstanding 84.5 77.3 76.7 76.2 76.2 64.8 67.1 66.6 66.6 66.6 66.6 66.6 66.6 66.6
Metric 2026 Q1 2025 Q4 2025 Q3 2025 Q2 2025 Q1 2024 Q4 2024 Q3 2024 Q2 2024 Q1 2023 Q4 2023 Q3 2023 Q1 2022 Q4
Current Assets
Cash & Cash Equivalents 33.7 32.5 45.1 14.6 41.5 257.1 43.4 25.2 77.5 8.3 10.3 (143.5) 88.1
Short-Term Investments 1,042.5 709.7 635.1 646.4 647.0 484.9 497.3 527.7 489.0 179.4 193.5 287.0 55.3
Net Receivables 1.3 0.7 0.5 0.6 0.3 0.8 0.1 0 0 0.1 0.0 0 0.3
Inventory 1.5 1.6 1.5 0 0 0 0 0 0 0 0 0 0
Other Current Assets 23.1 15.1 13.5 0 12.4 11.4 11.2 0.2 0.2 6.4 6.0 0 3.4
Total Current Assets 1,102.1 759.5 695.8 673.0 701.2 754.2 552.1 563.9 578.6 194.1 209.7 143.5 147.2
Non-Current Assets
Property, Plant & Equipment 19.6 19.6 19.5 1.2 1.3 0.5 0.3 0.4 0.4 0.5 0.6 0 0.5
Goodwill 10.3 10.3 12.8 0 0 0 0 0 0 0 0 0 0
Intangible Assets 0.6 0.6 1.7 0 0 0 0 0 0 0 0 0 0
Long-Term Investments 0 0 0 0 0 0 0 0 0 0 0 0 0
Other Non-Current Assets 2.7 1.7 0.1 27.2 25.7 0.1 0.1 0.1 0.1 4.7 1.6 (143.5) 0.0
Total Non-Current Assets 33.1 32.1 34.1 28.4 27.0 0.6 0.4 0.5 0.5 5.2 2.2 (143.5) 0.5
Total Assets 1,135.3 791.6 729.9 701.4 728.2 754.8 552.5 564.3 579.1 199.3 211.9 0 147.7
Current Liabilities
Account Payables 8.2 5.7 9.2 7.1 6.7 6.5 4.1 4.5 4.7 3.2 2.0 0 1.0
Short-Term Debt 1.1 0.9 0 0 0 0 0 0 0 0.6 0 0 9.0
Deferred Revenue 0 0 0.3 0 0 0 0 0 0 0 0 0 0
Other Current Liabilities 25.9 24.2 6.6 0.2 2.8 0.4 5.0 0.1 0.3 0.5 4.4 0 0.2
Total Current Liabilities 35.2 30.8 30.5 30.4 22.6 21.4 15.6 11.9 10.0 14.3 11.7 0 15.4
Non-Current Liabilities
Long-Term Debt 6.5 6.1 3 0 0 0 0 0 0 0 0 0 6.5
Deferred Tax Liabilities 0.3 0.3 1.6 0 0 0 0 0 0 0 0 0 0
Other Non-Current Liabilities 1.5 1.7 3.8 0 0 0 0 0 0 0.0 0.0 0 0.4
Total Non-Current Liabilities 8.3 8.2 11.7 0.7 0.8 0.1 0.1 0.1 0.2 0.3 0.3 0 7.1
Total Liabilities 43.5 39.0 42.3 31.1 23.4 21.4 15.7 12.0 10.2 14.5 12.0 0 22.6
Stockholders' Equity
Common Stock 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0 0.0 0 0
Retained Earnings (439.2) (379.0) (337.7) (293.9) (252.4) (218.0) (186.2) (165.8) (146.9) (129.9) (113.8) 0 (81.3)
Accumulated Other Comprehensive Income 0 0 0 0 0 0 0 0 0 0 0 (77.7) 0
Total Stockholders' Equity 1,091.8 752.6 687.6 670.4 704.8 733.4 536.8 552.4 568.9 184.8 199.9 125.2 125.2
Total Liabilities & Equity 1,135.3 791.6 729.9 701.4 728.2 754.8 552.5 564.3 579.1 199.3 211.9 125.2 147.7
Debt Metrics
Total Debt 7.6 7.0 7.2 1.0 1.0 0.2 0.3 0.4 0.4 1.0 0.5 0 15.9
Net Debt (26.1) (25.5) (37.9) (13.6) (40.4) (256.8) (43.1) (24.8) (77.1) (7.2) (9.8) 143.5 (72.2)
Metric 2026 Q1 2025 Q4 2025 Q3 2025 Q2 2025 Q1 2024 Q4 2024 Q3 2024 Q2 2024 Q1 2023 Q4 2023 Q3 2023 Q2 2023 Q1 2022 Q4
Operating Activities
Net Income (60.2) (41.3) (43.8) (41.4) (34.5) (31.8) (20.4) (18.9) (16.9) (16.6) (11.8) (11.6) (8.7) (8.4)
Depreciation & Amortization 0.8 0.8 0.4 0.2 0.0 0 0.0 0.0 0.0 (0.0) 0.0 0.0 0.0 0.0
Stock-Based Compensation 0 7.2 7.3 7.0 5.2 5.0 2.6 2.2 1.5 0.8 0.4 0.2 0.2 0.1
Change in Working Capital (5.8) (4.0) (2.9) 8.7 0.5 4.9 3.4 3.0 (8.4) 2.2 0.2 0.3 0.4 1.3
Other Non-Cash Items 8.2 1.0 0.0 (2.4) (0.5) 1.2 (1.6) (2.5) (2.2) (2.4) 0.3 0.4 0.1 0.1
Operating Cash Flow (56.9) (36.2) (38.9) (28.0) (29.3) (20.7) (15.9) (16.1) (26.0) (16.1) (10.8) (10.8) (8.0) (6.8)
Investing Activities
Capital Expenditure (0.3) (0.0) (0.1) (0.0) (0.0) (0.2) 0.0 (0.0) (0.0) 0 0.0 0 0 0
Acquisitions 0 0 (22.0) 0 0 0 0 0 0 0 0 0 0 0
Purchases of Investments (587.4) (297.7) (240.3) (168.0) (361.9) (217.1) (169.2) (206.3) (453.3) (379.5) (192.1) (32.3) (78.7) (55.3)
Sales/Maturities of Investments 252.9 222.2 251.4 170.4 200.1 228.2 201.2 170.1 145.9 0 30.7 135.7 0 0
Other Investing Activities 0 0 26 (1) (25) 0 0 0 0 396.4 (1.4) 0 0 0
Investing Cash Flow (334.8) (75.5) 15.0 1.4 (186.8) 10.9 32.0 (36.2) (307.4) 16.9 (162.8) 103.4 (78.7) (55.3)
Financing Activities
Net Debt Issuance 0 0 0 0 0 0.4 0 0 (0.4) (0.0) (0.1) (15.4) (0.8) 0
Stock Repurchased 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Dividends Paid 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Other Financing Activities (0.2) 0 5.4 0 0 (0.4) 0 0 (3.4) (2.9) 105.9 0.2 0.1 0
Financing Cash Flow 393.0 99.1 54.4 (0.3) 0.5 223.4 2.2 0.0 402.7 (2.9) 105.9 (15.2) (0.8) 56.7
Cash Position
Net Change in Cash 1.2 (12.7) 30.5 (26.8) (215.6) 213.7 18.3 (52.3) 69.2 (2.0) (67.8) 77.3 (87.5) (5.5)
Cash at Beginning 32.5 45.1 14.6 41.5 257.1 43.4 25.2 77.5 8.3 10.3 78.0 0.7 88.1 93.6
Cash at End 33.7 32.5 45.1 14.6 41.5 257.1 43.4 25.2 77.5 8.3 10.3 78.0 0.7 88.1
Free Cash Flow (57.2) (36.2) (39.0) (28.0) (29.3) (20.9) (15.9) (16.1) (26.0) (16.1) (10.8) (10.8) (8.0) (6.8)
Key Metrics 2026 Q1 2025 Q4 2025 Q3 2025 Q2 2025 Q1 2024 Q4 2024 Q3 2024 Q2 2024 Q1 2023 Q4 2023 Q3 2023 Q2 2023 Q1 2022 Q4
Income Statement
Revenue 1.1 2.3 1.7 0 0.1 0.5 0.0 0.1 0.5 0.0 0.0 0 0.2 0
Gross Profit (1.9) (0.6) 0.1 0 0.1 0.5 0.0 0.1 0.5 (0.0) (11.7) (0.0) (7.6) (0.0)
Operating Income (66.4) (48.7) (51.1) (48.7) (42.2) (38.0) (28.3) (25.9) (22.5) (18.9) (14.0) (12.3) (9.7) (9.3)
Net Income (60.2) (41.3) (43.8) (41.4) (34.5) (31.8) (20.4) (18.9) (16.9) (16.1) (11.8) (11.6) (8.7) (8.4)
EPS (Diluted) -0.71 -0.52 -0.57 -0.54 -0.45 -0.49 -0.30 -0.28 -0.22 -0.33 -0.28 -0.17 -0.13 -0.13
Balance Sheet
Cash & Equivalents 33.7 32.5 45.1 14.6 41.5 257.1 43.4 25.2 77.5 8.3 10.3 (143.5) 88.1
Total Assets 1,135.3 791.6 729.9 701.4 728.2 754.8 552.5 564.3 579.1 199.3 211.9 0 147.7
Total Debt 7.6 7.0 7.2 1.0 1.0 0.2 0.3 0.4 0.4 1.0 0.5 0 15.9
Stockholders' Equity 1,091.8 752.6 687.6 670.4 704.8 733.4 536.8 552.4 568.9 184.8 199.9 125.2 125.2
Cash Flow
Operating Cash Flow (56.9) (36.2) (38.9) (28.0) (29.3) (20.7) (15.9) (16.1) (26.0) (16.1) (10.8) (10.8) (8.0) (6.8)
Capital Expenditure (0.3) (0.0) (0.1) (0.0) (0.0) (0.2) 0.0 (0.0) (0.0) 0 0.0 0 0 0
Free Cash Flow (57.2) (36.2) (39.0) (28.0) (29.3) (20.9) (15.9) (16.1) (26.0) (16.1) (10.8) (10.8) (8.0) (6.8)